Takeda Pharmaceutical (TAK) Retained Earnings: 2018-2025
Historic Retained Earnings for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $7.8 billion.
- Takeda Pharmaceutical's Retained Earnings fell 17.08% to $7.8 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $7.8 billion, marking a year-over-year decrease of 17.08%. This contributed to the annual value of $7.8 billion for FY2025, which is 19.18% down from last year.
- Latest data reveals that Takeda Pharmaceutical reported Retained Earnings of $7.8 billion as of FY2025, which was down 19.18% from $9.6 billion recorded in FY2024.
- Takeda Pharmaceutical's 5-year Retained Earnings high stood at $14.2 billion for FY2021, and its period low was $7.8 billion during FY2025.
- In the last 3 years, Takeda Pharmaceutical's Retained Earnings had a median value of $9.6 billion in 2024 and averaged $9.6 billion.
- Its Retained Earnings has fluctuated over the past 5 years, first grew by 13.00% in 2021, then decreased by 19.18% in 2025.
- Over the past 5 years, Takeda Pharmaceutical's Retained Earnings (Yearly) stood at $14.2 billion in 2021, then fell by 7.46% to $13.2 billion in 2022, then dropped by 13.44% to $11.4 billion in 2023, then dropped by 15.44% to $9.6 billion in 2024, then fell by 19.18% to $7.8 billion in 2025.